Orexo is a specialty pharmaceutical company that focuses on developing druga for the treatment of opioid dependence.Read more
Orexo's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 74.8M. Over the last four quarters, Orexo's revenue has decreased by 31.3%. Specifically, in Q1 2021's revenue was $13.2M; in Q4 2020, it was $15.8M; in Q3 2020, it was $16.7M; in Q2 2020, Orexo's revenue was $19.2M.